| Evan Charles Seby, DPT | |
|
4702 E Main St, Belleville, PA 17004-9251 | |
| (717) 935-2105 | |
| Not Available |
| Full Name | Evan Charles Seby |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine & Rehabilitation |
| Location | 4702 E Main St, Belleville, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295454411 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 030685 (Pennsylvania) | Primary |
| Entity Name | Drayer Physical Therapy Institute Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538122700 PECOS PAC ID: 8224948666 Enrollment ID: O20040126000110 |
News Archive
The discovery of a potential "Achilles heel" in Nef, the protein that is crucial to HIV virulence and its capacity to trigger AIDS, paves the way for the development of a new class of drugs against the virus.
EFT BioTech Holdings, Inc., a proprietary e-commerce solutions Company providing "made in the USA" health, beauty and nutriceutical products under the EFT brand to its affiliate member network, boasting almost one million members strong, reports Secretary Hillary Clinton fully engaged with Vietnamese counterparts for progress, prosperity and peace at the same time EFT reports standing room only of over 2,000 people in Vietnam at its first major affiliate membership drive in the region.
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).
A special newly discovered biomarker, "Gb3," potentially related to the survival of heart disease patients, could change the way the country's No. 1 killer is monitored in the future, according to research published in the Feb. 4 edition of the Journal of the American Heart Association.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Evan Charles Seby, DPT 408 S Logan Blvd, Lewistown, PA 17044-1100 Ph: (717) 437-4410 | Evan Charles Seby, DPT 4702 E Main St, Belleville, PA 17004-9251 Ph: (717) 935-2105 |
News Archive
The discovery of a potential "Achilles heel" in Nef, the protein that is crucial to HIV virulence and its capacity to trigger AIDS, paves the way for the development of a new class of drugs against the virus.
EFT BioTech Holdings, Inc., a proprietary e-commerce solutions Company providing "made in the USA" health, beauty and nutriceutical products under the EFT brand to its affiliate member network, boasting almost one million members strong, reports Secretary Hillary Clinton fully engaged with Vietnamese counterparts for progress, prosperity and peace at the same time EFT reports standing room only of over 2,000 people in Vietnam at its first major affiliate membership drive in the region.
Antigenics Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP), of the European Medicines Agency (EMEA), has verbally informed the Company at an oral meeting to anticipate a negative opinion on the marketing authorization application (MAA) for Oncophage (vitespen) in early-stage, localized renal cell carcinoma (kidney cancer).
A special newly discovered biomarker, "Gb3," potentially related to the survival of heart disease patients, could change the way the country's No. 1 killer is monitored in the future, according to research published in the Feb. 4 edition of the Journal of the American Heart Association.
› Verified 8 days ago